Literature DB >> 22123157

Anaphylactic reaction after injection of glatiramer acetate (Copaxone®) in patients with relapsing-remitting multiple sclerosis.

Annette Baumgartner, Oliver Stich, Sebastian Rauer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22123157     DOI： 10.1159/000334107

Source DB:  PubMed          Journal:  Eur Neurol        ISSN： 0014-3022            Impact factor:   1.710


× No keyword cloud information.
  4 in total

Review 1.  Interferon beta and glatiramer acetate therapy.

Authors:  Corey A McGraw; Fred D Lublin
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620

Review 2.  Immediate reactions with glatiramer acetate: Diagnosis of allergy and desensitization protocols.

Authors:  Guadalupe Marco-Martín; Pilar Tornero; Alicia Prieto; Alejandro La Rotta; Teresa Herrero; Maria Luisa Baeza
Journal:  Neurol Clin Pract       Date:  2020-04

3.  Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis.

Authors:  Alessandra Lugaresi; Maria di Ioia; Daniela Travaglini; Erika Pietrolongo; Eugenio Pucci; Marco Onofrj
Journal:  Neuropsychiatr Dis Treat       Date:  2013-06-24       Impact factor: 2.570

4.  Flare up reaction during provocation test to glatiramer acetate in a patient with allergy to interferon beta1a.

Authors:  Paola L Minciullo; Gioacchino Calapai; Sebastiano Gangemi
Journal:  Allergy Asthma Immunol Res       Date:  2014-02-07       Impact factor: 5.764
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.